M Ventures Performance Materials Fund Sven Harmsen Investment - PowerPoint PPT Presentation

M Ventures Performance Materials Fund Sven Harmsen Investment Director M ERCK V ENTURES B.V. Amsterdam, Netherlands, a subsidiary of Merck KGaA, Darmstadt, Germany

THE ORIGINAL THE ORIGINAL THE ORIGINAL THE ORIGINAL In 1887, Merck KGaA, Merck KGaA, Darmstadt, Germany Darmstadt, opened its own office Germany – in New York, which the original gave rise to the holds the global subsidiary Merck & rights to the Merck Co., Inc., Kenilworth, name and brand. NJ three years later. Exceptions are As a result of World Canada and the War I, this subsidiary United States, was expropriated in where we operate as 1917 and has been an EMD Serono, independent company MilliporeSigma and ever since. EMD Performance Materials. 2

What we do Performance Healthcare Life Science Materials Prescription medicines to treat, for Innovative tools and laboratory A wide range of specialty chemicals, example, cancer, multiple sclerosis supplies for the life science industry such as liquid crystals for displays, and infertility, over-the-counter that make research and biotech effect pigments for coatings and pharmaceuticals for everyday health production easier, faster and more cosmetics, or high-tech materials protection or to provide fast relief of successful. for the electronics industry. colds and pain, as well as innovations in the areas of allergies and biosimilars . 3

Merck Ventures mission Providing a window on innovation “Merck Ventures drives innovation and backs entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of Merck’s current and future businesses” Outside – In Inside – Out Venture investments in Creation of new businesses external innovation around Merck technologies 4

From MS Ventures to Merck Ventures The expanded Merck Venture Fund Merck Fund organization Fund organization Ventures Sector dedicated teams Sector dedicated teams Performance New Healthcare Life Sciences Materials Businesses Investment professionals Investment professionals Strategic Investment Fund Strategic Investment Fund €150 mio €50 mio €50 mio €50 mio Seed investments & Company creation Direct investments in syndicated deals Primary financing mechanisms Merck Spin-offs Israel Incubator 5

Portfolio company overview by Fund and Therapeutic Area 20 Active companies in HealthCare; 2 investments in New Businesses Health Care Health Care Health Care Health Care Health Care New Oncology Autoimmune Disc. Tech Fertility Neurology Businesses Active Exit Merck Serono Spin-off Legacy BD Deal 6 Write-offs

Merck Ventures the corporate venture capital arm of Merck Four dedicated funds to add another tool to capture innovation for the three high-tech businesses Performance New Healthcare Life Science Materials Businesses € 150M € 50M € 50M € 50M Investments in the next Investments in the life Investments in Investments in new generation of drugs science business materials and business fields applications Biologics and small- Next generation tools Materials for and To essentially establish a • • • • molecules and services for biotech applications of organic forth business pillar for research & production electronics the Merck Group Investment focus: • Oncology, Immunology Tools and laboratory New applications of LC’s Very broad mandate • • • & Immuno-Oncology supply for the academic Pigments and related Anything in the fields of research and industrial • • Finding novel solutions functional materials digital, agriculture, food testing • for patients and beyond High-tech materials for • integrated circuits, esp. advanced packaging 7

Merck Ventures – Performance Materials R&D priorities Technology hot spots and search fields by BU Display Integrated Circuit Pigments & Advanced Materials Materials Functional Materials Technologies � New non-display applications � Technologies where materials � Functional materials for � New electrode- and emitter for LCs, e.g. are the enabler of further cosmetics, food, pharma materials for OLEDs miniaturization − Smart Antennas � Anti-aging � Cadmium-free quantum dots � Focus: Advanced Packaging and applications thereof − Light Guides and � 3D printing (additive Waveplates − Thermal interface mat. manufacturing) � Materials for µ-LED displays − Smart Vizor technologies � Improved perovskite SC & − Mat. for embedded acceptor materials for OPV � Holography components � Hybrid Electronics and � Technologies enabling flexible − Surface modification Electronics packaging LC displays − Low shrinkage mat. 8

What does Merck Ventures hold for Merck’s future? Trends significantly influencing the materials business in the next 3-5 years New visual Miniaturization of Internet of things Wearables & Beauty & anti-aging environments Electronics flexible electronics Technologies End of “Moore’s Law” 50 billion connected Trend of self- Cosmetics growth in enabling flexible and requires new devices by 2020 optimization spurs anti-aging segment is transparent displays solutions for further require new, demand for expected to continue as well as VR & AR miniaturization based powerful materials healthcare and with increasingly aging devices on new materials omitting rare earth fitness devices society elements enabled by flexible electronics 9

M ERCK V ENTURES B.V., Amsterdam, the Netherlands, a subsidiary of Merck KGaA, Darmstadt, Germany